JP2006232679A5 - - Google Patents

Download PDF

Info

Publication number
JP2006232679A5
JP2006232679A5 JP2005045597A JP2005045597A JP2006232679A5 JP 2006232679 A5 JP2006232679 A5 JP 2006232679A5 JP 2005045597 A JP2005045597 A JP 2005045597A JP 2005045597 A JP2005045597 A JP 2005045597A JP 2006232679 A5 JP2006232679 A5 JP 2006232679A5
Authority
JP
Japan
Prior art keywords
concentration
aqueous solution
solution containing
agent
containing vanadium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005045597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006232679A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005045597A priority Critical patent/JP2006232679A/ja
Priority claimed from JP2005045597A external-priority patent/JP2006232679A/ja
Publication of JP2006232679A publication Critical patent/JP2006232679A/ja
Publication of JP2006232679A5 publication Critical patent/JP2006232679A5/ja
Pending legal-status Critical Current

Links

JP2005045597A 2005-02-22 2005-02-22 バナジウムイオン含有高血圧及び高中性脂肪血症改善剤並びに高中性脂肪血症患者用血糖降下剤 Pending JP2006232679A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005045597A JP2006232679A (ja) 2005-02-22 2005-02-22 バナジウムイオン含有高血圧及び高中性脂肪血症改善剤並びに高中性脂肪血症患者用血糖降下剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005045597A JP2006232679A (ja) 2005-02-22 2005-02-22 バナジウムイオン含有高血圧及び高中性脂肪血症改善剤並びに高中性脂肪血症患者用血糖降下剤

Publications (2)

Publication Number Publication Date
JP2006232679A JP2006232679A (ja) 2006-09-07
JP2006232679A5 true JP2006232679A5 (cg-RX-API-DMAC10.html) 2008-04-03

Family

ID=37040734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005045597A Pending JP2006232679A (ja) 2005-02-22 2005-02-22 バナジウムイオン含有高血圧及び高中性脂肪血症改善剤並びに高中性脂肪血症患者用血糖降下剤

Country Status (1)

Country Link
JP (1) JP2006232679A (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007007183A (es) * 2004-12-16 2008-01-14 Genmedica Therapeutics Sl Aminas, combinacion de aminas y vanadio y sales de amina y vanadio para el tratamiento o prevencion de dislipidemia.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006035047A (ja) * 2004-07-23 2006-02-09 Shimizu Corp バナジウム含有水の製造方法

Similar Documents

Publication Publication Date Title
EA200900392A1 (ru) Комбинированное лечение сахарного диабета
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
EP2452687A3 (en) Methods and compositions for prevention and treatment of diabetic and aged skin
WO2007024700A3 (en) Exendin for treating diabetes and reducing body weight
EP1756074A4 (en) 1,2,4-OXADIAZOLE DERIVATIVES AS DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
WO2007005759A3 (en) Analyte sensors and compositions for use therein
EA200900940A1 (ru) Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное
EP1623046A4 (en) Compositions and methods for treating severe acute respiratory syndrome (SARS)
WO2008008887A3 (en) Gpr119 agonists for treating metabolic disorders
WO2006015035A8 (en) Useful compounds for hpv infection
WO2006099941A8 (de) Aminocarbonyl substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2006058648A3 (en) Biaryloxymethylarene carboxylic acids
JP2009178558A5 (cg-RX-API-DMAC10.html)
JP2008531742A5 (cg-RX-API-DMAC10.html)
EP2158901A3 (en) Alpha aztreonam lysinate
EA200870088A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови
WO2006130174A3 (en) Compositions comrising nebivolol
IL185807A0 (en) Use of amino-substituted benzimidazoles
FR2883181B1 (fr) Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
WO2006110810A3 (en) Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine
WO2007116428A3 (en) Oral pharmaceutical composition containing cystine or cysteine with glutathione against oxidative stress resulting from haemodialysis
WO2002020464A8 (en) Benzene tricarboxylic acid amides as insulin receptor activators
WO2006091962A3 (en) Detection of compounds that affect therapeutic activity
WO2007111933A3 (en) Pharmaceutical compositions comprising a hypoglycemic agent and methods of using same
JP2005516073A5 (cg-RX-API-DMAC10.html)